Literature DB >> 21765873

Multiple sclerosis and chronic cerebrospinal venous insufficiency: a critical review.

Amer M Awad1, Ellen Marder, Ron Milo, Olaf Stüve.   

Abstract

Chronic cerebrospinal venous insufficiency (CCSVI) was recently proposed as a contributing factor in the pathology of multiple sclerosis. This concept has gained remarkable attention, partly because endovascular neurointervention has been suggested as a treatment strategy. This review summarizes available evidence and provides a critical analysis of the published data. Currently, there is inconclusive evidence to support CCSVI as an etiological factor in patients with multiple sclerosis. Endovascular procedures should not be undertaken outside of controlled clinical trials.

Entities:  

Keywords:  chronic cerebrospinal venous insufficiency; multiple sclerosis

Year:  2011        PMID： 21765873      PMCID： PMC3131174          DOI： 10.1177/1756285611405565

Source DB:  PubMed          Journal:  Ther Adv Neurol Disord        ISSN： 1756-2856            Impact factor:   6.570


  36 in total

Review 1.  The prevalence of multiple sclerosis in the world: an update.

Authors:  G Rosati
Journal:  Neurol Sci       Date:  2001-04       Impact factor: 3.307

2.  ["Chronic cerebrospinal venous insufficiency" and multiple sclerosis: critical analysis and first observation in an unselected cohort of MS patients].

Authors:  C Krogias; A Schröder; H Wiendl; R Hohlfeld; R Gold
Journal:  Nervenarzt       Date:  2010-06       Impact factor: 1.214

3.  Normal CSF ferritin levels in MS suggest against etiologic role of chronic venous insufficiency.

Authors:  V Worthington; J Killestein; M J Eikelenboom; C E Teunissen; F Barkhof; C H Polman; B M J Uitdehaag; A Petzold
Journal:  Neurology       Date:  2010-09-29       Impact factor: 9.910

4.  A reassessment of the distribution of multiple sclerosis.

Authors:  J F Kurtzke
Journal:  Acta Neurol Scand       Date:  1975-02       Impact factor: 3.209

5.  Detection of intracranial venous reflux in patients of transient global amnesia.

Authors:  C-P Chung; H-Y Hsu; A-C Chao; F-C Chang; W-Y Sheng; H-H Hu
Journal:  Neurology       Date:  2006-06-27       Impact factor: 9.910

6.  Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination.

Authors:  C Lucchinetti; W Brück; J Parisi; B Scheithauer; M Rodriguez; H Lassmann
Journal:  Ann Neurol       Date:  2000-06       Impact factor: 10.422

7.  [Three patients with transient global amnesia following an increased venous pressure: a study using 3.0 Tesla diffusion-weighted magnetic resonance imaging].

Authors:  Toshiyuki Sakai; Masahide Kondo; Hidekazu Tomimoto
Journal:  Rinsho Shinkeigaku       Date:  2010-07

8.  A prospective open-label study of endovascular treatment of chronic cerebrospinal venous insufficiency.

Authors:  Paolo Zamboni; Roberto Galeotti; Erica Menegatti; Anna Maria Malagoni; Sergio Gianesini; Ilaria Bartolomei; Francesco Mascoli; Fabrizio Salvi
Journal:  J Vasc Surg       Date:  2009-12       Impact factor: 4.268

Review 9.  Cerebral venous infarction: the pathophysiological concept.

Authors:  B Schaller; R Graf
Journal:  Cerebrovasc Dis       Date:  2004-07-22       Impact factor: 2.762

10.  Rate of pregnancy-related relapse in multiple sclerosis. Pregnancy in Multiple Sclerosis Group.

Authors:  C Confavreux; M Hutchinson; M M Hours; P Cortinovis-Tourniaire; T Moreau
Journal:  N Engl J Med       Date:  1998-07-30       Impact factor: 91.245
View more
  2 in total

1.  No evidence for impairment of venous hemodynamics in children or young adults with pediatric-onset multiple sclerosis.

Authors:  S Laughlin; C K Macgowan; J Traubici; K Chan; S Khan; D L Arnold; R A Marrie; B Banwell
Journal:  AJNR Am J Neuroradiol       Date:  2013-07-18       Impact factor: 3.825

2.  COVID-Related Leukoencephalopathy: Unusual MRI Features and Comparability to Delayed Post Hypoxic Ischemic Encephalopathy.

Authors:  Manzoor Ahmed; Waqar Haider Gaba; Fahim M Khan; Rabab Al Mansoori; Abd Al Kareem Adi
Journal:  Radiol Case Rep       Date:  2022-01-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.